(90)Y-DOTATOC Dosimetry–Based Personalized Peptide Receptor Radionuclide Therapy

Pretherapy PET with (86)Y-DOTATOC is considered the ideal dosimetry protocol for (90)Y-DOTATOC therapy; however, its cost, limited availability, and need for infusion of amino acids to mimic the therapy administration limit its use in the clinical setting. The goal of this study was to develop a dos...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:J Nucl Med
Egile Nagusiak: Menda, Yusuf, Madsen, Mark T., O’Dorisio, Thomas M., Sunderland, John J., Watkins, G. Leonard, Dillon, Joseph S., Mott, Sarah L., Schultz, Michael K., Zamba, Gideon K.D., Bushnell, David L., O’Dorisio, M. Sue
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Society of Nuclear Medicine 2018
Gaiak:
Theranostics
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC6225542/
https://ncbi.nlm.nih.gov/pubmed/29523629
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2967/jnumed.117.202903
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak